← Open Payments lookup

LINDSEY LASSITER: Open Payments

NPI 1225325632 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,202 in 112 payments from 20 companies in 2025. Trend: 2023 $1,862 · 2024 $2,068 · 2025 $2,202

Food & beverage: $2,102Education: $100
CompanyPaymentsAmount
GlaxoSmithKline, LLC.23$443
AstraZeneca Pharmaceuticals LP18$368
Mallinckrodt Hospital Products Inc.14$360
United Therapeutics Corporation9$175
Regeneron Healthcare Solutions, Inc.6$148
Boehringer Ingelheim Pharmaceuticals, Inc.7$121
GENZYME CORPORATION5$91
Insmed, Inc.4$78
Liquidia Technologies, Inc.5$66
Merck Sharp & Dohme LLC2$58

Products named: ACTHAR, DUPIXENT, TRELEGY ELLIPTA, NUCALA, TEZSPIRE, Tyvaso, BREZTRI, FASENRA.

Industry payments across MS — which companies pay providers there.